Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.

Choe R, Durduran T.

IEEE J Sel Top Quantum Electron. 2012 Jul;18(4):1367-1386. Epub 2011 Dec 2.

2.

Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy.

Falou O, Soliman H, Sadeghi-Naini A, Iradji S, Lemon-Wong S, Zubovits J, Spayne J, Dent R, Trudeau M, Boileau JF, Wright FC, Yaffe MJ, Czarnota GJ.

Transl Oncol. 2012 Aug;5(4):238-46. Epub 2012 Aug 1.

3.

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).

Esserman LJ, Berry DA, Cheang MC, Yau C, Perou CM, Carey L, DeMichele A, Gray JW, Conway-Dorsey K, Lenburg ME, Buxton MB, Davis SE, van't Veer LJ, Hudis C, Chin K, Wolf D, Krontiras H, Montgomery L, Tripathy D, Lehman C, Liu MC, Olopade OI, Rugo HS, Carpenter JT, Livasy C, Dressler L, Chhieng D, Singh B, Mies C, Rabban J, Chen YY, Giri D, Au A, Hylton N; I-SPY 1 TRIAL Investigators..

Breast Cancer Res Treat. 2012 Apr;132(3):1049-62. doi: 10.1007/s10549-011-1895-2. Epub 2011 Dec 25.

4.

Monitoring the response to primary medical therapy for breast cancer using three- dimensional time-resolved optical mammography.

Enfield LC, Cantanhede G, Westbroek D, Douek M, Purushotham AD, Hebden JC, Gibson AP.

Technol Cancer Res Treat. 2011 Dec;10(6):533-47.

PMID:
22066594
5.

Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.

Cerussi AE, Tanamai VW, Hsiang D, Butler J, Mehta RS, Tromberg BJ.

Philos Trans A Math Phys Eng Sci. 2011 Nov 28;369(1955):4512-30. doi: 10.1098/rsta.2011.0279.

6.

MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?

McGuire KP, Toro-Burguete J, Dang H, Young J, Soran A, Zuley M, Bhargava R, Bonaventura M, Johnson R, Ahrendt G.

Ann Surg Oncol. 2011 Oct;18(11):3149-54. doi: 10.1245/s10434-011-1912-z. Epub 2011 Sep 27.

PMID:
21947592
7.

Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment.

Roblyer D, Ueda S, Cerussi A, Tanamai W, Durkin A, Mehta R, Hsiang D, Butler JA, McLaren C, Chen WP, Tromberg B.

Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14626-31. doi: 10.1073/pnas.1013103108. Epub 2011 Aug 18.

8.

Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer?

Pakalniskis MG, Wells WA, Schwab MC, Froehlich HM, Jiang S, Li Z, Tosteson TD, Poplack SP, Kaufman PA, Pogue BW, Paulsen KD.

Radiology. 2011 May;259(2):365-74. doi: 10.1148/radiol.11100699. Epub 2011 Mar 15.

9.

Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy.

Arlinghaus LR, Li X, Levy M, Smith D, Welch EB, Gore JC, Yankeelov TE.

J Oncol. 2010;2010. pii: 919620. doi: 10.1155/2010/919620. Epub 2010 Sep 29.

10.

Computer aided automatic detection of malignant lesions in diffuse optical mammography.

Busch DR, Guo W, Choe R, Durduran T, Feldman MD, Mies C, Rosen MA, Schnall MD, Czerniecki BJ, Tchou J, DeMichele A, Putt ME, Yodh AG.

Med Phys. 2010 Apr;37(4):1840-9.

11.

Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer.

Soliman H, Gunasekara A, Rycroft M, Zubovits J, Dent R, Spayne J, Yaffe MJ, Czarnota GJ.

Clin Cancer Res. 2010 May 1;16(9):2605-14. doi: 10.1158/1078-0432.CCR-09-1510. Epub 2010 Apr 20.

12.

Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction.

Dehghani H, Eames ME, Yalavarthy PK, Davis SC, Srinivasan S, Carpenter CM, Pogue BW, Paulsen KD.

Commun Numer Methods Eng. 2008 Aug 15;25(6):711-732.

13.

Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes.

Jiang S, Pogue BW, Carpenter CM, Poplack SP, Wells WA, Kogel CA, Forero JA, Muffly LS, Schwartz GN, Paulsen KD, Kaufman PA.

Radiology. 2009 Aug;252(2):551-60. doi: 10.1148/radiol.2522081202. Epub 2009 Jun 9.

14.

Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography.

Choe R, Konecky SD, Corlu A, Lee K, Durduran T, Busch DR, Pathak S, Czerniecki BJ, Tchou J, Fraker DL, Demichele A, Chance B, Arridge SR, Schweiger M, Culver JP, Schnall MD, Putt ME, Rosen MA, Yodh AG.

J Biomed Opt. 2009 Mar-Apr;14(2):024020. doi: 10.1117/1.3103325.

15.

Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization.

Zhu Q, Tannenbaum S, Hegde P, Kane M, Xu C, Kurtzman SH.

Neoplasia. 2008 Oct;10(10):1028-40.

16.

Assessing the future of diffuse optical imaging technologies for breast cancer management.

Tromberg BJ, Pogue BW, Paulsen KD, Yodh AG, Boas DA, Cerussi AE.

Med Phys. 2008 Jun;35(6):2443-51.

17.

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.

Kaufmann M, von Minckwitz G, Bear HD, Buzdar A, McGale P, Bonnefoi H, Colleoni M, Denkert C, Eiermann W, Jackesz R, Makris A, Miller W, Pierga JY, Semiglazov V, Schneeweiss A, Souchon R, Stearns V, Untch M, Loibl S.

Ann Oncol. 2007 Dec;18(12):1927-34. Epub 2007 Nov 12. Review.

PMID:
17998286
18.

Intrinsic tumor biomarkers revealed by novel double-differential spectroscopic analysis of near-infrared spectra.

Kukreti S, Cerussi A, Tromberg B, Gratton E.

J Biomed Opt. 2007 Mar-Apr;12(2):020509.

19.

Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy.

Cerussi A, Hsiang D, Shah N, Mehta R, Durkin A, Butler J, Tromberg BJ.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4014-9. Epub 2007 Feb 28.

20.

Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy.

Tromberg BJ, Cerussi A, Shah N, Compton M, Durkin A, Hsiang D, Butler J, Mehta R.

Breast Cancer Res. 2005;7(6):279-85. Epub 2005 Nov 28. Review.

Supplemental Content

Support Center